SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-006241
Filing Date
2019-04-12
Accepted
2019-04-12 11:34:53
Documents
2
Period of Report
2019-04-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k041119_immucellcorp.htm 8-K 17543
2 AMENDED AND RESTATED INCENTIVE COMPENSATION AGREEMENT WITH MS. BOBBI JO BROCKMAN f8k041119ex99-1_immucell.htm EX-99.1 10896
  Complete submission text file 0001213900-19-006241.txt   29525
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 19745623
SIC: 2835 In Vitro & In Vivo Diagnostic Substances